AG006U7K

50370-12-2 | Cefadroxil

Chemical structure of Cefadroxil, CAS 50370-12-2
AG006U7K
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 50370-12-2
Catalog Number AG006U7K(AGN-PC-0S872G)
Chemical Name Cefadroxil
EC Number 256-555-6
IUPAC Name (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
InChI InChI=1S/C16H17N3O5S/c1-7-6-25-15-11(14(22)19(15)12(7)16(23)24)18-13(21)10(17)8-2-4-9(20)5-3-8/h2-5,10-11,15,20H,6,17H2,1H3,(H,18,21)(H,23,24)/t10-,11-,15-/m1/s1
InChI Key BOEGTKLJZSQCCD-UEKVPHQBSA-N
MDL Number MFCD00865091
Molecular Formula C16H17N3O5S
Molecular Weight 363.3883
NSC Number 756664
SMILES N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)C)C1=CC=C(C=C1)O
UNII Q525PA8JJB
Synonyms
4 Hydroxycephalexin, 4-Hydroxycephalexin, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-, Bidocef, BL S 578, BL S578, BL-S 578, BL-S578, BLS 578, BLS578, Cefadroxil, Cefadroxil Anhydrous, Cefadroxil Monohydrate, Cephadroxyl, Duricef, S 578, S-578, S578, Ultracef, cefadroxil, Cephadroxil, 50370-12-2, Cefadroxil anhydrous, Cefadroxilo, Cefadroxilum, D-Cefadroxil, Duricef, Ultracef, BL-S578, UNII-Q525PA8JJB, BL-S 578, 66592-87-8, CHEBI:3479, (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, Q525PA8JJB, Cefadroxilum [INN-Latin], Cefadroxilo [INN-Spanish], S 578, S-578, DSSTox_CID_2749, CDX, Cefadroxil, 95-105%, DSSTox_RID_76714, Cefradroxil, DSSTox_GSID_22749, MJF-11567-3, (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, p-Hydroxycephalexine, EINECS 256-555-6, (6R,7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, (6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2R)-amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R,7R)-, Cefadroxil [INN], Sumacef (TN), (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, C16H17N3O5S, Cefadrops, CEFADROXIL/CEFADROXIL HEMIHYDRATE, NCGC00016858-01, CAS-50370-12-2, Cefadroxil, Anhydrous, Cefadroxil (JP17), Spectrum_000104, Prestwick0_000434, Prestwick1_000434, Prestwick2_000434, Prestwick3_000434, Spectrum2_000087, Spectrum4_000266, Spectrum5_000663, Epitope ID:117131, AC1L2J3O, CHEMBL1644, BSPBio_000448, KBioGR_000732, KBioSS_000544, MLS002207219, DivK1c_000409, SCHEMBL151320, SPBio_000014, SPBio_002387, Cefadroxil, analytical standard, BPBio1_000494, GTPL4831, DTXSID8022749, CTK8F8512, HMS501E11, KBio1_000409, KBio2_000544, KBio2_003112, KBio2_005680, BOEGTKLJZSQCCD-UEKVPHQBSA-N, NINDS_000409, HMS1569G10, HMS2096G10, HMS3713G10, Pharmakon1600-01500163, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6-alpha,7-beta(R*)))-, HY-B1190, ZINC3830391, Tox21_110651, BBL033696, BDBM50350467, MFCD00865091, NSC756664, STK801939, AKOS005622555, Tox21_110651_1, API0006601, CCG-220434, CS-4696, DB01140, MCULE-6475996520, NSC-756664, IDI1_000409, NCGC00179556-01, NCGC00179556-03, AS-11655, SC-74593, SMR001306770, SBI-0051305.P003, AB00513838, FT-0603067, ST51014960, C06878, D00257, 592C878, I04-8441, Cefadroxil monohydrate, Antibiotic for Culture Media Use Only, (7R)-7-((R)-2-amino-2-(4-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(2R)-2-amino-2-(4-hydroxyphenyl)acetylamino](7R,7aR)-3-methyl-6-oxo-2H,7H-a zetidino[2,1-b]1,3-thiazine-4-carboxylic acid, 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-3,4-didehydrocepham-4-carboxylic acid, Oracefal, cefadrox, Cephadroxyl, Bidocef, Bidocel, Cefamox, Sumacef, Cefadroxil monohydrate, Moxacef Kapseln, Cefos Granulat, Baxan Kapseln, Kefroxil Kapseln, Omnidrox Kapseln, Curisafe (TN), 4 Hydroxycephalexin, 4-Hydroxycephalexin, Cefadroxil 1-wasser, Cefadroxil (JP15), D0X9ZC, CEFADROXIL HEMIHYDRATE, FLUOCINOLONE ACETONIDE, Cefadroxil anhydrous [USAN], BLS578, C16H17N3O5S.H2O, BL S578, BLS 578, Cefadroxil [USAN:BAN:INN:JAN], Cefadroxil [USAN:INN:BAN:JAN], BL S 578, CID47965, C16-H17-N3-O5-S, Cefdroxil pound non-sterile pound(c), UNII-280111G160, Cefadroxil [USAN:USP:INN:BAN:JAN], CS-O-06205, MJF 11567-3, C16-H17-N3-O5-S.H2-O, S578, C-2462, D002434, 7-[D-(-)alpha-amino-alpha-(4-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid, (6R,7R)-7-((R)-2-Amino-2-(p-hydroxyphenyl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid monohydrate, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(R*)))-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl) acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, monohydrate, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, [6R-[6.alpha.,7.beta.(R*)]]-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[amino(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-, monohydrate, [6R-[6.alpha.,7.beta.(R*)]]-, 67-73-2, 7beta-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,4-didehydrocepham-4-carboxylic acid,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited